- Home
- NCRA vs ERNA Comparison
NCRA vs ERNA Comparison
Compare NCRA & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCRA | ERNA |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 10.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NCRA | ERNA |
|---|---|---|
| Price | $0.73 | $1.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.4K | ★ 196.2K |
| Earning Date | 04-01-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,106,275.00 | $1,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $1.08 |
| 52 Week High | $2.40 | $9.23 |
Technical Indicators
Market Signals| Indicator | NCRA | ERNA |
|---|---|---|
| Relative Strength Index (RSI) | 37.82 | 45.55 |
| Support Level | $0.82 | $1.14 |
| Resistance Level | $0.96 | $1.26 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 0.03 | 24.07 |
Price Performance
Historical ComparisonAbout NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.